Intricon launches Center of Excellence for biosensor devices

Intricon, developer and manufacturer of medical devices powered by smart miniaturised electronics, has announced that it has launched a new Biosensors Center of Excellence (CoE).

“OEMs and start-ups need an approach like this because there are important intricacies in creating medical biosensor devices vs. consumer biosensor products,” said Scott Longval, Intricon CEO. “There’s a mass movement toward biosensors for medical applications, such as hospital at home and remote patient monitoring. Creating and commercialising first- and next-generation medical biosensor devices are more complex than ever and must happen at scale and cost profile to meet the demands of these exploding use cases.”

Longval adds that Intricon’s focus on biosensors is a natural evolution for the company, given its more than four decades of experience in wearable medical biosensor devices. 

“We’re responding to the industry, which needs deep expertise in the many complex capabilities required to successfully compete in this quickly emerging device category,” said Dave Liebl, Intricon chief commercial and technology officer.

The Intricon Biosensor CoE team has deep expertise in high-density microelectronics, miniaturisation, ultra-low power, miniature moulding, firmware development, and wireless communication, including Bluetooth and Bluetooth Low Energy technology. Intricon plans to expand its team of biosensors experts, with key hires in 2023.

Intricon’s other sensor-driven expertise is in developing and manufacturing medical devices that use electromagnetic (EM) navigation. The company has modelling and engineering systems to design and produce micro-coils that meet electromagnetic goals such as induction, resistance, sensitivity, and localisation performance.